Monitoring and antibacterial treatment for postoperative bacterial overgrowth in Crohn's disease

被引:16
|
作者
Funayama, Y
Sasaki, I
Naito, H
Fukushima, K
Shibata, C
Masuko, T
Takahashi, K
Ogawa, H
Sato, S
Ueno, T
Noguchi, M
Hiwatashi, N
Matsuno, S
机构
[1] Tohoku Univ, Sch Med, Dept Surg 1, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Sch Med, Dept Internal Med 3, Aoba Ku, Sendai, Miyagi 9808574, Japan
关键词
Crohn's disease; bacterial overgrowth syndrome; hydrogen breath test; antibiotics;
D O I
10.1007/BF02236706
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PURPOSE: Bacterial overgrowth sometimes complicates the clinical course of Crohn's disease and may lead to inappropriate treatment. To clarify the effect of antibiotic therapy, we monitored the hydrogen concentration in expiratory breath after fasting. METHODS: We evaluated 18 patients (15 males; median age, 32.7; range, 22.3-60 years) for postoperative bacterial overgrowth symptoms and for intestinal dilation by plain abdominal x-ray. Five patients had ileitis and 13 patients had ileocolitis. Various intestinal resections were performed in all, and strictureplasties were done at the same time in 13 patients. The median postoperative period was 10.2 (range, 1.2-102) months. Nine patients, who had symptoms such as bloating, nausea, vomiting, or pain, were classified as the symptomatic group, whereas nine other patients, who had no symptoms, were classified as the symptom-free group. Sixteen patients who bad undergone intestinal resections for noninflammatory bowel disease served as the control group. After overnight fasting, hydrogen concentration in end-expiratory breath was measured with gas chromatography. At the same time clinical examinations of white blood cell count, hemoglobin, total protein, serum albumin, iron, sialic acid, and C-reactive protein in the peripheral blood were performed. To assess the effect of antibacterial treatment, changes in symptoms were assessed in eight patients who received antibacterial treatment. Hydrogen concentration was measured repeatedly before and after treatment in six patients. RESULTS: The symptomatic group had an expiratory hydrogen concentration level significantly higher (median, 40; range, 20-139 ppm) than the control group (median, 3; range, 1-6 ppm) and the symptom-free group (median, 4; range, 1-10 ppm). After the antibiotic treatment the symptoms were improved in all of the patients, and the hydrogen concentration level was significantly reduced (median, 4.5; range, 2-13 ppm). CONCLUSIONS: Antibacterial treatment was useful in the postoperative patients whose assessments were complicated by bacterial overgrowth. Using a hydrogen breath test, bacterial overgrowth was effectively monitored and managed, effecting a change in clinical symptoms.
引用
收藏
页码:1072 / 1077
页数:6
相关论文
共 50 条
  • [21] Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease
    Klaus, Jochen
    Spaniol, Ulrike
    Adler, Guido
    Mason, Richard A.
    Reinshagen, Max
    von Tirpitz, Christian C.
    BMC GASTROENTEROLOGY, 2009, 9
  • [22] Postoperative Recurrence of Crohn's Disease: Pathophysiology, Diagnosis and Treatment
    Di Sario, Antonio
    Sassaroli, Paola
    Daretti, Luigi
    Annulli, Giulia
    Schiada, Laura
    Falcioni, Giorgia
    Bendia, Emanuele
    Antuono, Simone
    Benedetti, Antonio
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2017, 18 (12) : 979 - 988
  • [23] Prevent postoperative recurrence of paediatric Crohn’s disease by risk-based treatment and early monitoring
    Esther S. Kim
    Young-A. Heo
    Drugs & Therapy Perspectives, 2020, 36 : 377 - 381
  • [24] Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence
    Buisson, Anthony
    Chevaux, Jean-Baptiste
    Bommelaer, Gilles
    Peyrin-Biroulet, Laurent
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (06) : 453 - 460
  • [25] Prevent postoperative recurrence of paediatric Crohn's disease by risk-based treatment and early monitoring
    Kim, Esther S.
    Heo, Young-A.
    DRUGS & THERAPY PERSPECTIVES, 2020, 36 (09) : 377 - 381
  • [26] CROHN'S DISEASE Bacterial clearance in Crohn's disease pathogenesis
    Fava, Francesca
    Danese, Silvio
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (03) : 126 - 128
  • [27] ROLE OF BACTERIAL OVERGROWTH IN CROHN'S DISEASE PATIENTS WITH ILEOCOLIC RESECTION: GLUCOSE BREATH TEST EVALUATION
    Astegiano, M.
    Brignolo, P.
    Adriani, A.
    Reggiani, S.
    Sguazzini, C.
    Ribaldone, D.
    Sapone, N.
    Dileo, I.
    Resegotti, A.
    Pellicano, R.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S67 - S67
  • [28] Prevalence, predisposing factors and clinical relevance of small intestinal bacterial overgrowth in patients with Crohn's disease
    Klaus, Jochen
    Adler, Guido
    von Boyen, Georg B.
    GASTROENTEROLOGY, 2008, 134 (04) : A203 - A203
  • [29] Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease
    Wright, Emily K.
    Kamm, Michael A.
    De Cruz, Peter
    Hamilton, Amy L.
    Selvaraj, Fabiyola
    Princen, Fred
    Gorelik, Alexandra
    Liew, Danny
    Prideaux, Lani
    Lawrance, Ian C.
    Andrews, Jane M.
    Bampton, Peter A.
    Jakobovits, Simon L.
    Florin, Timothy H.
    Gibson, Peter R.
    Debinski, Henry
    Macrae, Finlay A.
    Samuel, Douglas
    Kronborg, Ian
    Radford-Smith, Graham
    Gearry, Richard B.
    Selby, Warwick
    Bell, Sally J.
    Brown, Steven J.
    Connell, William R.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (06): : 653 - 661
  • [30] Non-invasive Serological Monitoring for Crohn's Disease Postoperative Recurrence
    Hamilton, Amy L.
    De Cruz, Peter
    Wright, Emily K.
    Dervieux, Thierry
    Jain, Anjali
    Kamm, Michael A.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (12): : 1797 - 1807